Resources
Upcoming Events
Article
Recent FDA-approved drugs of interest to underwriters
Understand their health implications so you can confidently assess risk.
Read more
Article
Juvenile life insurance applicants have more health data than you think
Routine care and clinical encounters found in medical claims data give underwriters meaningful visibility into early‑life health.
Read more
Article
Seeing a GLP‑1 on a life insurance applicant profile? Start with this chart.
Here's a handy underwriting guide for interpreting GLP-1 mortality risk signals.
Read more
ARTICLE
How underwriters should interpret GLP-1 prescriptions (and what they signal about risk)
As GLP-1 indications expand, accurate risk assessment depends on confirming diagnosis, companion therapy signals, and persistence in prescription data.
Read more
Article
Outpaced by medical inflation? Workers’ comp fee schedules can’t save you
Benchmarking exposes hidden overspend, empowers early intervention, and delivers measurable savings—before rising costs erode your bottom line.
Read more
Article
What’s up with “upcoding”?
Although upcoding fraud is a concern for payers, its impact on claims data for mortality risk assessment is negligible.
Read more
Article
Cystic fibrosis is an improving condition—put your guidelines on notice
Heads up, forward-thinking underwriters: Treatment for CF is dramatically increasing patient longevity.
Read more